Human LUAD frequently harbors KRAS or EGFR mutations and data presented in this report suggested that lung adenocarcinoma cells harboring EGFR mutations may be more sensitive to the loss of IWS1 than KRAS mutant cells (Figs. 5, 6, 7 and Supplementary Fig. 10a). This evidence concerns the gene KRAS and lung adenocarcinoma.